These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 9034789)
1. 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. White PC; Mune T; Agarwal AK Endocr Rev; 1997 Feb; 18(1):135-56. PubMed ID: 9034789 [TBL] [Abstract][Full Text] [Related]
2. 11 beta-Hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess. White PC; Mune T; Rogerson FM; Kayes KM; Agarwal AK Pediatr Res; 1997 Jan; 41(1):25-9. PubMed ID: 8979285 [TBL] [Abstract][Full Text] [Related]
3. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess. Whorwood CB; Stewart PM J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678 [TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of 11 beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess. White PC; Mune T; Rogerson FM; Kayes KM; Agarwal AK Steroids; 1997 Jan; 62(1):83-8. PubMed ID: 9029720 [TBL] [Abstract][Full Text] [Related]
5. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Mune T; Rogerson FM; Nikkilä H; Agarwal AK; White PC Nat Genet; 1995 Aug; 10(4):394-9. PubMed ID: 7670488 [TBL] [Abstract][Full Text] [Related]
6. Human kidney 11 beta-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform. Stewart PM; Murry BA; Mason JI J Clin Endocrinol Metab; 1994 Aug; 79(2):480-4. PubMed ID: 8045966 [TBL] [Abstract][Full Text] [Related]
7. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension. Odermatt A; Dick B; Arnold P; Zaehner T; Plueschke V; Deregibus MN; Repetto H; Frey BM; Frey FJ; Ferrari P J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516 [TBL] [Abstract][Full Text] [Related]
8. 11beta-hydroxysteroid dehydrogenase and its role in the syndrome of apparent mineralocorticoid excess. White PC Am J Med Sci; 2001 Dec; 322(6):308-15. PubMed ID: 11780688 [TBL] [Abstract][Full Text] [Related]
9. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency]. Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418 [TBL] [Abstract][Full Text] [Related]
10. Cortisol to cortisone: glucocorticoid to mineralocorticoid. Stewart PM; Mason JI Steroids; 1995 Jan; 60(1):143-6. PubMed ID: 7792800 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the human gene encoding the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Agarwal AK; Rogerson FM; Mune T; White PC J Steroid Biochem Mol Biol; 1995 Dec; 55(5-6):473-9. PubMed ID: 8547172 [TBL] [Abstract][Full Text] [Related]
12. Cortisol as a mineralocorticoid in human disease. Stewart PM J Steroid Biochem Mol Biol; 1999; 69(1-6):403-8. PubMed ID: 10419018 [TBL] [Abstract][Full Text] [Related]
13. Steroid hormones and hypertension: the cortisol-cortisone shuttle. Stewart PM; Whorwood CB; Walker BR Steroids; 1993 Dec; 58(12):614-20. PubMed ID: 8116018 [TBL] [Abstract][Full Text] [Related]
14. 11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome. Stewart PM; Walker BR; Holder G; O'Halloran D; Shackleton CH J Clin Endocrinol Metab; 1995 Dec; 80(12):3617-20. PubMed ID: 8530609 [TBL] [Abstract][Full Text] [Related]
15. Gene structure and chromosomal localization of the human HSD11K gene encoding the kidney (type 2) isozyme of 11 beta-hydroxysteroid dehydrogenase. Agarwal AK; Rogerson FM; Mune T; White PC Genomics; 1995 Sep; 29(1):195-9. PubMed ID: 8530071 [TBL] [Abstract][Full Text] [Related]
16. [11 beta-hydroxysteroid-dehydrogenase: characteristics and the clinical significance of a key enzyme in cortisol metabolism]. Kerstens MN; Dullaart RP Ned Tijdschr Geneeskd; 1999 Mar; 143(10):509-14. PubMed ID: 10321259 [TBL] [Abstract][Full Text] [Related]
19. Apparent mineralocorticoid excess: type I and type II. Mantero F; Palermo M; Petrelli MD; Tedde R; Stewart PM; Shackleton CH Steroids; 1996 Apr; 61(4):193-6. PubMed ID: 8732999 [TBL] [Abstract][Full Text] [Related]
20. Medical and physiological aspects of the 11beta-hydroxysteroid dehydrogenase system. Seckl JR; Chapman KE Eur J Biochem; 1997 Oct; 249(2):361-4. PubMed ID: 9370341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]